Development of growth factor-immobilizable material for hepatocyte transplantation

Yung Te Hou, Hiroyuki Ijima, Nana Shirakigawa, Takayuki Takei, Koei Kawakami

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Growth factor (GF)-immobilizable materials were developed as a practical hepatocyte transplantation method for reconstructing a tissue-like structure in liver tissue engineering. Two GF-immobilizable scaffolds, namely single hepatocyte-embedded, heparin-immobilized, collagen-gel-filled polyurethane foam, and hepatocyte spheroid-embedded, heparin-immobilized, collagen-gel-filled polyurethane foam were developed by covalently incorporating heparin into collagen gel, using 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide/. N-hydroxysuccinimide for hepatocyte transplantation. Seventy percent partial hepatectomy (PH) was performed at the same time after hepatocyte transplantation. Angiogenesis efficiency and viability of transplanted cells are discussed in terms of normalized hemoglobin content, nuclear density and histological observations after transplantation. In summary, the normalized hemoglobin content and viability of transplanted cells were higher in GF-immobilized scaffolds with PH pretreatment than in the other scaffolds with/without PH pretreatment. These materials have the potential for in vivo hepatocyte transplantation, as GFs released from remnant liver were easily incorporated into the heparin-immobilized collagen gel system. These GF-heparin complexes may promote the survival of embedded cells. Furthermore, the transplantation of spheroids promoted increased angiogenesis compared with hepatocytes, and resulted in sufficient vascularization for cell survival.

Original languageEnglish
Pages (from-to)172-181
Number of pages10
JournalBiochemical Engineering Journal
Volume69
DOIs
Publication statusPublished - Dec 15 2012

Fingerprint

Hepatocytes
Intercellular Signaling Peptides and Proteins
Transplantation
Heparin
Collagen
Cell Survival
Hepatectomy
Gels
Hemoglobin
Scaffolds
Liver
Polyurethanes
Foams
Hemoglobins
Ethyldimethylaminopropyl Carbodiimide
Tissue Engineering
Scaffolds (biology)
Tissue engineering
Cells
Tissue

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Bioengineering
  • Biomedical Engineering
  • Environmental Engineering

Cite this

Development of growth factor-immobilizable material for hepatocyte transplantation. / Hou, Yung Te; Ijima, Hiroyuki; Shirakigawa, Nana; Takei, Takayuki; Kawakami, Koei.

In: Biochemical Engineering Journal, Vol. 69, 15.12.2012, p. 172-181.

Research output: Contribution to journalArticle

Hou, Yung Te ; Ijima, Hiroyuki ; Shirakigawa, Nana ; Takei, Takayuki ; Kawakami, Koei. / Development of growth factor-immobilizable material for hepatocyte transplantation. In: Biochemical Engineering Journal. 2012 ; Vol. 69. pp. 172-181.
@article{e6944b419deb4c87b11d99f38236e3df,
title = "Development of growth factor-immobilizable material for hepatocyte transplantation",
abstract = "Growth factor (GF)-immobilizable materials were developed as a practical hepatocyte transplantation method for reconstructing a tissue-like structure in liver tissue engineering. Two GF-immobilizable scaffolds, namely single hepatocyte-embedded, heparin-immobilized, collagen-gel-filled polyurethane foam, and hepatocyte spheroid-embedded, heparin-immobilized, collagen-gel-filled polyurethane foam were developed by covalently incorporating heparin into collagen gel, using 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide/. N-hydroxysuccinimide for hepatocyte transplantation. Seventy percent partial hepatectomy (PH) was performed at the same time after hepatocyte transplantation. Angiogenesis efficiency and viability of transplanted cells are discussed in terms of normalized hemoglobin content, nuclear density and histological observations after transplantation. In summary, the normalized hemoglobin content and viability of transplanted cells were higher in GF-immobilized scaffolds with PH pretreatment than in the other scaffolds with/without PH pretreatment. These materials have the potential for in vivo hepatocyte transplantation, as GFs released from remnant liver were easily incorporated into the heparin-immobilized collagen gel system. These GF-heparin complexes may promote the survival of embedded cells. Furthermore, the transplantation of spheroids promoted increased angiogenesis compared with hepatocytes, and resulted in sufficient vascularization for cell survival.",
author = "Hou, {Yung Te} and Hiroyuki Ijima and Nana Shirakigawa and Takayuki Takei and Koei Kawakami",
year = "2012",
month = "12",
day = "15",
doi = "10.1016/j.bej.2012.09.007",
language = "English",
volume = "69",
pages = "172--181",
journal = "Biochemical Engineering Journal",
issn = "1369-703X",
publisher = "Elsevier",

}

TY - JOUR

T1 - Development of growth factor-immobilizable material for hepatocyte transplantation

AU - Hou, Yung Te

AU - Ijima, Hiroyuki

AU - Shirakigawa, Nana

AU - Takei, Takayuki

AU - Kawakami, Koei

PY - 2012/12/15

Y1 - 2012/12/15

N2 - Growth factor (GF)-immobilizable materials were developed as a practical hepatocyte transplantation method for reconstructing a tissue-like structure in liver tissue engineering. Two GF-immobilizable scaffolds, namely single hepatocyte-embedded, heparin-immobilized, collagen-gel-filled polyurethane foam, and hepatocyte spheroid-embedded, heparin-immobilized, collagen-gel-filled polyurethane foam were developed by covalently incorporating heparin into collagen gel, using 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide/. N-hydroxysuccinimide for hepatocyte transplantation. Seventy percent partial hepatectomy (PH) was performed at the same time after hepatocyte transplantation. Angiogenesis efficiency and viability of transplanted cells are discussed in terms of normalized hemoglobin content, nuclear density and histological observations after transplantation. In summary, the normalized hemoglobin content and viability of transplanted cells were higher in GF-immobilized scaffolds with PH pretreatment than in the other scaffolds with/without PH pretreatment. These materials have the potential for in vivo hepatocyte transplantation, as GFs released from remnant liver were easily incorporated into the heparin-immobilized collagen gel system. These GF-heparin complexes may promote the survival of embedded cells. Furthermore, the transplantation of spheroids promoted increased angiogenesis compared with hepatocytes, and resulted in sufficient vascularization for cell survival.

AB - Growth factor (GF)-immobilizable materials were developed as a practical hepatocyte transplantation method for reconstructing a tissue-like structure in liver tissue engineering. Two GF-immobilizable scaffolds, namely single hepatocyte-embedded, heparin-immobilized, collagen-gel-filled polyurethane foam, and hepatocyte spheroid-embedded, heparin-immobilized, collagen-gel-filled polyurethane foam were developed by covalently incorporating heparin into collagen gel, using 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide/. N-hydroxysuccinimide for hepatocyte transplantation. Seventy percent partial hepatectomy (PH) was performed at the same time after hepatocyte transplantation. Angiogenesis efficiency and viability of transplanted cells are discussed in terms of normalized hemoglobin content, nuclear density and histological observations after transplantation. In summary, the normalized hemoglobin content and viability of transplanted cells were higher in GF-immobilized scaffolds with PH pretreatment than in the other scaffolds with/without PH pretreatment. These materials have the potential for in vivo hepatocyte transplantation, as GFs released from remnant liver were easily incorporated into the heparin-immobilized collagen gel system. These GF-heparin complexes may promote the survival of embedded cells. Furthermore, the transplantation of spheroids promoted increased angiogenesis compared with hepatocytes, and resulted in sufficient vascularization for cell survival.

UR - http://www.scopus.com/inward/record.url?scp=84867025612&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867025612&partnerID=8YFLogxK

U2 - 10.1016/j.bej.2012.09.007

DO - 10.1016/j.bej.2012.09.007

M3 - Article

VL - 69

SP - 172

EP - 181

JO - Biochemical Engineering Journal

JF - Biochemical Engineering Journal

SN - 1369-703X

ER -